OKYO Pharma News

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 10 01:24

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 4 18:35

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 2 19:04

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 30 02:32

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 22 19:01

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 21 19:06

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 20 20:12

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 9 20:04

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 31 20:01

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 8 13:00

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 5 13:00

OKYO Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Dec 21, 2023 20:35

OKYO Pharma | 424B5: Prospectus

Dec 21, 2023 06:30

OKYO Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Dec 19, 2023 05:56

OKYO Pharma | 424B5: Prospectus

Dec 16, 2023 06:46

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 4, 2023 20:00

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Nov 29, 2023 20:00

OKYO Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 2, 2023 04:55

OKYO Pharma | 424B5: Prospectus

Nov 1, 2023 04:59

OKYO Pharma | 4: Statement of changes in beneficial ownership of securities-Executive Chairman CERRONE GABRIELE M

Nov 1, 2023 04:15